Role Of Leukotrienes Receptor In Atherosclerosis - Bhalodia, Yagnik;Makawana, Ajit
26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
13 °P sammeln
  • Broschiertes Buch

Cardiovascular complications such as hypertension, atherosclerosis etc., are growing day by day and prevalence is even more in affluant society. Atherosclerosis is one of the most common cause of death all over the world. The importance of leukotrienes receptors in atherosclerosis are widely accepted. Here this book demonstrated that the montelukast, a cystenyl leukotirenes receptor antagonist inhibit the progression of atherosclerosis and reduces atherosclerotic index in rats. This book may useful to understand about importance of leukotriene receptors in atherosclerosis.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Cardiovascular complications such as hypertension, atherosclerosis etc., are growing day by day and prevalence is even more in affluant society. Atherosclerosis is one of the most common cause of death all over the world. The importance of leukotrienes receptors in atherosclerosis are widely accepted. Here this book demonstrated that the montelukast, a cystenyl leukotirenes receptor antagonist inhibit the progression of atherosclerosis and reduces atherosclerotic index in rats. This book may useful to understand about importance of leukotriene receptors in atherosclerosis.
Autorenporträt
Dr. Yagnik S. Bhalodia, M.Pharm., Ph.D., is working as an Associate Professor in Faculty of Pharmaceutical Sciences, C. U. Shah University, Wadhwan. He has been worked for ten years in pharmaceutical fields. He is having more than 30 publications in various international journal. He has been driving force behind research for many years.